Maximum Strength Medicated Foot Powder

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Maximum Strength Medicated Foot Powder
Generic name: MENTHOL
Manufacturer: Davion, Inc
Product type: HUMAN OTC DRUG
SPL set ID: 7b442d99-ac19-4f65-828d-954c5350ef5a
SPL ID: 9df9d907-df74-40b5-8462-c90a3e2e288d
Version: 5
Effective date: 2025-12-29
Source export date: 2026-10-12
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:55:14

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Maximum Strength Medicated Foot Powder	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		Davion, Inc	openfda.manufacturer_name
ndc	package	42669-283-01	openfda.package_ndc
ndc	product	42669-283	openfda.product_ndc
ndc11	package	42669028301	derived:openfda.package_ndc
rxcui		259579	openfda.rxcui
spl id		9df9d907-df74-40b5-8462-c90a3e2e288d	id
spl set id		7b442d99-ac19-4f65-828d-954c5350ef5a	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning For external use only Avoid contact with eyes Stop use and ask a doctor if condition worsens symptoms persist for more than 7 days or clear up and occur again within few days Keep out of reach of children In case of accidental ingestion, get medical help or contact a poison control center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.